Winning Health Technology Group Co., Ltd. (SHE:300253)

SHE:300253 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,632	2,782	3,161	3,091	2,749	2,264
Other Revenue	0.44	0.44	2.47	1.38	0.94	2.23
Revenue	2,633	2,782	3,163	3,093	2,750	2,267
Revenue Growth (YoY)	-17.95%	-12.05%	2.28%	12.46%	21.34%	18.79%
Cost of Revenue	1,522	1,623	1,741	1,742	1,476	1,041
Gross Profit	1,110	1,159	1,423	1,351	1,275	1,226
Selling, General & Admin	510.86	545.37	653.83	707.67	585.95	464.12
Research & Development	245.75	264.63	333.3	313.77	255.67	229.45
Other Operating Expenses	-103.19	-107.76	-99.28	25.8	-79.54	-80.1
Operating Expenses	839.8	888.61	1,027	1,282	995.35	748.5
Operating Income	270.55	270.25	395.28	69.54	279.34	477.18
Interest Expense	-66.76	-66.76	-64.05	-59.63	-46.68	-9.88
Interest & Investment Income	10.14	10.14	43.09	20.62	11.8	105.82
Currency Exchange Gain (Loss)	-	-	-0.01	-	0	-0.02
Other Non Operating Income (Expenses)	16.59	-5.32	0.78	-14.25	-22.38	-10.3
EBT Excluding Unusual Items	246.91	208.31	375.09	16.28	222.08	562.81
Impairment of Goodwill	-63.64	-63.64	-6.6	-22.94	-	-
Gain (Loss) on Sale of Investments	-90.86	-76.83	-50.46	-90.56	116.51	-34.69
Gain (Loss) on Sale of Assets	-0.4	-0.28	-0.43	-0.52	0.18	0.23
Asset Writedown	-22.82	-0.09	-0.05	-0.31	-0.31	-0.69
Legal Settlements	-	-	-0.26	-	-	-
Other Unusual Items	19.49	19.49	23.46	136.6	34.72	18.5
Pretax Income	88.67	86.96	340.75	38.54	373.17	546.16
Income Tax Expense	48.44	36.89	23.13	23.78	19.43	40.63
Earnings From Continuing Operations	40.23	50.07	317.62	14.76	353.73	505.53
Minority Interest in Earnings	36.33	37.83	40.34	93.88	24.44	-14.43
Net Income	76.56	87.89	357.96	108.64	378.17	491.1
Net Income to Common	76.56	87.89	357.96	108.64	378.17	491.1
Net Income Growth	-82.53%	-75.45%	229.49%	-71.27%	-22.99%	23.26%
Shares Outstanding (Basic)	2,166	2,154	2,147	2,139	2,143	2,125
Shares Outstanding (Diluted)	2,171	2,160	2,195	2,143	2,147	2,138
Shares Change (YoY)	-1.22%	-1.60%	2.42%	-0.22%	0.44%	1.15%
EPS (Basic)	0.04	0.04	0.17	0.05	0.18	0.23
EPS (Diluted)	0.04	0.04	0.16	0.05	0.18	0.23
EPS Growth	-82.31%	-75.05%	221.70%	-71.21%	-23.34%	21.86%
Free Cash Flow	181.63	101.71	-128.53	-223.26	81.83	203.36
Free Cash Flow Per Share	0.08	0.05	-0.06	-0.10	0.04	0.10
Dividend Per Share	0.015	0.015	0.020	0.010	0.020	0.025
Dividend Growth	-25.00%	-25.00%	100.00%	-50.00%	-20.00%	30.21%
Gross Margin	42.18%	41.65%	44.97%	43.69%	46.35%	54.08%
Operating Margin	10.28%	9.71%	12.50%	2.25%	10.16%	21.05%
Profit Margin	2.91%	3.16%	11.32%	3.51%	13.75%	21.67%
Free Cash Flow Margin	6.90%	3.66%	-4.06%	-7.22%	2.97%	8.97%
EBITDA	293.75	293.17	417.06	90.9	299.2	495.7
EBITDA Margin	11.16%	10.54%	13.18%	2.94%	10.88%	21.87%
D&A For EBITDA	23.2	22.91	21.77	21.35	19.86	18.52
EBIT	270.55	270.25	395.28	69.54	279.34	477.18
EBIT Margin	10.28%	9.71%	12.50%	2.25%	10.16%	21.05%
Effective Tax Rate	54.63%	42.42%	6.79%	61.71%	5.21%	7.44%
Revenue as Reported	2,782	2,782	3,163	3,093	2,750	2,267

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.